Follow RSS for latest reports on this topicStomach Cancer - Market Research and Reports

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2018 [Report Updated: 31-08-2018]

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2018 provides an overview of Transitional Cell Cancer (Urothelial Cell Cancer) clinical trials scenario. This report provides top line data relating to the clinical trials on Tran...Read More >>>

Published:
2018-08-31

Published by: Global Data

Prices Starting From:
$2500

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2018 [Report Updated: 14-08-2018]

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2018SummaryCancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) pipeline Target constitutes close to 18 molecules. Out of which a...Read More >>>

Published:
2018-08-14

Published by: Global Markets Direct

Prices Starting From:
$3500

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer [Report Updated: 01-07-2018]

Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast CancerSummaryBreast cancer remains a major global healthcare concern despite exceptional levels of public awareness about the disease. A lack of clear causative environmental factors and hereditary dispositioning have resulted in the incidence of breas...Read More >>>

Published:
2018-07-01

Published by: GBI Research

Prices Starting From:
$6995

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018 [Report Updated: 29-06-2018]

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2018, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.Kidney cancer also called renal cancer is a disease in which kidney cells become malignant (can...Read More >>>

Published:
2018-06-29

Published by: Global Markets Direct

Prices Starting From:
$2500

Oncology Nutrition Market by Cancer Type (Head & Neck, Stomach & Gastrointestinal, Liver, Pancreatic, Esophageal, Lung, Breast, Blood) - Global Forecast to 2023 [Report Updated: 30-04-2018]

“The oncology nutrition market is projected to grow at a CAGR of 8.7% between 2018 and 2023.”The oncology nutrition market is expected to reach USD 2.21 billion by 2023 from USD 1.46 billion in 2018, at a CAGR of 8.7%. The overall growth of the market is largely driven by the shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional fee...Read More >>>

Published:
2018-04-30

Published by: MarketsandMarkets

Prices Starting From:
$5650

Europe Cancer Therapeutics Market - Segmented by Drug Type, Cancer Type, and End User - Growth, Trends, and Forecast (2018 - 2023) [Report Updated: 01-03-2018]

The Europe cancer therapeutics market is expected to register a CAGR of 6.3% during the forecast period, 2018 to 2023. Germany dominates the market due to growing prevalence of cancer diseases and rapid adoption of new therapy and novel drugs in the country.High Prevalence and Incidence of Cancer in EuropeCancer represents second most important cause of death and morbidity in Europe, accounting f...Read More >>>

Published:
2018-03-01

Published by: Mordor Intelligence LLC

Prices Starting From:
$3850

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H1 2018 [Report Updated: 20-02-2018]

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H1 2018SummaryCancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Cancer/Testis Antigen 1 is a protein encoded by CTAG1A gene is ...Read More >>>

Published:
2018-02-20

Published by: Global Markets Direct

Prices Starting From:
$3500

Engineered T Cells Market by Type (Tumor Infiltrating Lymphocytes, T Cell Receptor, and Chimeric Antigen Receptor), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Leukemia, and Others), and End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2017-2023 [Report Updated: 01-01-2018]

T cell is a type of white blood cell, and plays an important role in cell-medicated immunity. Engineered T cells are genetically modified T cells, specifically altered for therapeutic actions against autoimmune diseases and various types of cancers. The engineered T cells are delivered into patient’s body to reduce toxicity levels and restrict antigen escape (inability of immune system to respon...Read More >>>

Published:
2018-01-01

Published by: Allied Market Research

Prices Starting From:
$3840

Cancer Supportive Care Products Market: Lung Cancer Segment Projected to Remain Dominant over the Forecast Period: Global Industry Analysis and Opportunity Assessment 2016-2021 [Report Updated: 23-12-2017]

With growing prevalence of cancer, the demand for cancer treatments, such as chemotherapy has also been consistently on the rise since the past decade. However, radiation therapy brings with it a host of side effects that are challenging for cancer patients to face while they undergo the course of treatment. While the cancer treatment realm is tremendously progressing, the incidences of side effec...Read More >>>

Published:
2017-12-23

Published by: Future Market Insights

Prices Starting From:
$5000

Global and Chinese Stomach Washing Machine Industry, 2017 Market Research Report [Report Updated: 19-12-2017]

The 'Global and Chinese Stomach Washing Machine Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Stomach Washing Machine industry with a focus on the Chinese market. The report provides key statistics on the market status of the Stomach Washing Machine manufacturers and is a valuable source of guidance and direction for companies a...Read More >>>

Published:
2017-12-19

Published by: Prof Research

Prices Starting From:
$3000

Global Cancer Diagnostics Market Segmentation Analysis 2017-2021: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains [Report Updated: 08-12-2017]

Complete report ,500.  DataPack (test volumes, sales forecasts, supplier shares) ,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the global cancer diagnostics market during the nex...Read More >>>

Published:
2017-12-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$34500

US Cancer Diagnostics Market Segmentation Analysis 2017-2021: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains [Report Updated: 08-12-2017]

Complete report ,800.  DataPack (test volumes, sales forecasts, supplier shares) ,400.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the US cancer diagnostics market during the next five yea...Read More >>>

Published:
2017-12-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$9800

China Molecular Diagnostics Market, Test Volume & Forecast by Oncology Test (Breast Cancer, Colorectal Cancer, Prostate Cancer) Infectious Disease Test (Virology, HPV), Genetic Test (Blood Screening, HLA) [Report Updated: 28-08-2017]

China molecular diagnostics market is expected to be more than USD 1.5 Billion by the year 2022. As a part of the evolution of medicine in China; en route for targeted therapy and recognizing the revenue as well as profits in this new market, Diagnostics instruments are the foundation of the biotechnology industry and the pharmaceutical industry are appropriately important in molecular diagnostics...Read More >>>

Published:
2017-08-28

Published by: Renub

Prices Starting From:
$1200

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2017 [Report Updated: 22-08-2017]

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2017SummaryCancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Cancer/Testis Antigen 1 is a protein encoded by CTAG1A gene is ...Read More >>>

Published:
2017-08-22

Published by: Global Markets Direct

Prices Starting From:
$3500

Companion Diagnostics Market by Technology (PCR, IHC, NGS, ISH), Indication (Breast cancer, NSCLC, Colorectal cancer, Neurological disorders, Infectious Diseases), End User (Pharmaceutical & Biopharmaceutical Companies, Reference Lab) - Global Forecast to 2022 [Report Updated: 01-08-2017]

“Global companion diagnostics market projected to grow at CAGR of 20.1%”The global companion diagnostics market is projected to reach USD 6.51 billion by 2022 from USD 2.61 billion in 2017, at a CAGR of 20.1%. The growth of this market is majorly driven by the factors such as improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe, a...Read More >>>

Published:
2017-08-01

Published by: MarketsandMarkets

Prices Starting From:
$5650

Oncology Drugs Market Global Report 2017 Including: Lung Cancer, Pancreatic Cancer, Breast Cancer, Prostate Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Non-Small Cell Lung Cancer , Kidney Cancer, Brain Tumor, Thyroid Cancer, Skin Cancer, Bladder Cancer, Cervical Cancer, Blood Cancer, Others (Kaposi Sarcoma, Aids-Related Lymphoma, Anal Cancer, Bone Cancer, Retinoblastoma, Testicula [Report Updated: 17-07-2017]

The global oncology drugs market was estimated to be around 8 billion as of 2016. The oncology drugs market market made up around 11% Read More >>>

Published:
2017-07-17

Published by: The Business Research Company

Prices Starting From:
$4000

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2017 [Report Updated: 30-06-2017]

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2017, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.Kidney cancer also called renal cancer is a disease in which kidney cells become malignant (can...Read More >>>

Published:
2017-06-30

Published by: Global Markets Direct

Prices Starting From:
$2500

Cancer Immunotherapy Market by Technology (Monoclonal Antibodies, Cytokines & Immunomodulators, and Others), by Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, and Others) by End User (Hospitals, Cancer Research Centers, and Clinics) - Global Opportunity Analysis and Industry Forecast, 2014-2022 [Report Updated: 18-05-2017]

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS1.3. KEY MARKET SEGMENT1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.5. ANALYST TOOLS AND MODELSCHAPTER 2 EXECUTIVE SUMMARY2.1. KEY FINDINGS OF THE STUDY2.2. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. KEY FINDINGS3.2.1. Top investment pockets3.2.2. Top winning strategies3.3....Read More >>>

Published:
2017-05-18

Published by: Allied Market Research

Prices Starting From:
$5370

2017 Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains [Report Updated: 30-03-2017]

Complete report ,500.  DataPack (test volumes, sales forecasts, supplier shares) ,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the global cancer diagnostics market during the nex...Read More >>>

Published:
2017-03-30

Published by: Venture Planning Group (VPG)

Prices Starting From:
$34500

2017 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains [Report Updated: 30-03-2017]

Complete report ,800.  DataPack (test volumes, sales forecasts, supplier shares) ,400.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new report from VPGMarketResearch.com is based on a study of the major business opportunities emerging in the US cancer diagnostics market during the next five yea...Read More >>>

Published:
2017-03-30

Published by: Venture Planning Group (VPG)

Prices Starting From:
$9800

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016 [Published by Global Markets Direct]

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.Kidney cancer also called renal cancer is a disease in which kidney cells become malignant (c...Read More >>>

Published:
2016-12-21

Published by: Global Markets Direct

Prices Starting From:
$2500

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market [Published by GBI Research]

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive MarketSummaryCancer is a group of diseases characterized by abnormal cell growth. It is a multi-step process, as a single mutation is almost certainly insufficient to cause a cell to become malignant. A number of cellular processes must be deregulated...Read More >>>

Published:
2016-12-01

Published by: GBI Research

Prices Starting From:
$4995

Cancer Biomarkers Market by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, and Cytogenetics Based Tests), Biomolecules (Genetic Biomarkers, Protein Biomarkers, and Glycoprotein Biomarkers), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Stomach Cancer, and Other Cancers), Application (Diagnostics, Drug Discovery and Development, Prognosti [Report Updated: 01-12-2016]

Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indicat...Read More >>>

Published:
2016-12-01

Published by: Allied Market Research

Prices Starting From:
$5370

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016 [Published by Global Markets Direct]

Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016SummaryGlobal Markets Direct’s, ‘Cancer/Testis Antigen 1 (Autoimmunogenic Cancer/Testis Antigen NY ESO 1 or Cancer/Testis Antigen 6.1 or L Antigen Family Member 2 or CTAG1A or CTAG1B) - Pipeline Review, H2 2016’, prov...Read More >>>

Published:
2016-11-30

Published by: Global Markets Direct

Prices Starting From:
$3500

Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020) [Published by Daedal Research]

Scope of the ReportThe report entitled “Global Cancer Diagnostic Market with Focus on Lung and Breast Cancer (2016-2020)”, provides analysis of the global cancer diagnostics market and the US cancer diagnostics market, with detailed analysis of market size and growth, penetration and market share. The report also provides the analysis of the global and the US cancer market, by prevalence, new ...Read More >>>

Published:
2016-10-01

Published by: Daedal Research

Prices Starting From:
$800

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016 [Published by Global Data]

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016 provides an overview of Transitional Cell Cancer (Urothelial Cell Cancer) clinical trials scenario. This report provides top line data relating to the clinical trials on Tran...Read More >>>

Published:
2016-08-30

Published by: Global Data

Prices Starting From:
$2500

Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains [Report Updated: 02-08-2016]

Complete report ,500.  DataPack (test volumes, sales forecasts, supplier shares) ,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific information needs and budget.This new report from VPG Market Research is based on a study of the major business opportunities emerging in the global cancer diagnostics market during the next&...Read More >>>

Published:
2016-08-02

Published by: Venture Planning Group (VPG)

Prices Starting From:
$34500

US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains [Report Updated: 02-08-2016]

Complete report ,800.  DataPack (test volumes, sales forecasts, supplier shares) ,400.  The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.This new report from VPG Market Research is based on a study of the major business opportunities emerging in the US cancer diagnostics market during the next five years...Read More >>>

Published:
2016-08-02

Published by: Venture Planning Group (VPG)

Prices Starting From:
$9800

Cancer Hormone Therapy Market: By Therapy Type (Neoadjuvant & Adjuvant Treatment), By Cancer Treated (Breast, Prostate, Ovarian, Thyroid, Kidney & Other Cancers) & By Geography-Forecast (2016-2021) [Report Updated: 26-02-2016]

Hormones are natural substances produced by glands in our bodies. They are carried in our bloodstream and act as messengers between one part of our body and another. Hormone therapy for cancer is the use of medicines to block the effects of hormones which are used by some of the cancers to grow. Cancer hormone therapy does not work for all types of cancer. However doctors and surgeons use hormone ...Read More >>>

Published:
2016-02-26

Published by: Industry ARC

Prices Starting From:
$5250

Cancer Immunotherapy Market: By Cancer Type (Cancer Monoclonal Antibodie, Immune Checkpoint Inhibitors, Cancer Vaccines, Non-Specific Immunotherapies & Others) & Geography-Forecast (2016-2021) [Report Updated: 26-02-2016]

Immunotherapy is also known as biologic therapy for cancer treatment. Immunotherapy is treatment which is carried out using certain parts of a person’s immune system to fight diseases such as cancer. Immunotherapy is can be done in two ways which includes either stimulating person’s own immune system to work harder or smarter to attack cancer cells or injecting immune system components, such a...Read More >>>

Published:
2016-02-26

Published by: Industry ARC

Prices Starting From:
$5250

Cancer Diagnostics Market: By Product Type (Next-generation Sequencing, Microarrays, PCR, Flow Cytometry, In situ Hybridization, Immunohistochemistry, Imaging Instruments, & Biopsy), By Cancer Treated & By Geography-Forecast (2016-2021) [Report Updated: 25-02-2016]

Cancer can be defined as abnormal division of cells in an uncontrollable fashion. This uncontrollable division of cells starts with a single cell which grow and multiply to form tumor in the body. Globally increasing instances of deaths due to cancer and people with cancer coupled with increasing awareness and developing healthcare infrastructure is expected to drive the demand for cancer diagnost...Read More >>>

Published:
2016-02-25

Published by: Industry ARC

Prices Starting From:
$5250

2016 World Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains (DataPack) [Published by Venture Planning Group (VPG)]

Published:
2016-02-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$21100

2016 US Cancer Diagnostics Market Segmentation Analysis: Cancer Clinics, Commercial Labs, Hospitals, Physician Offices--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains (DataPack) [Published by Venture Planning Group (VPG)]

Published:
2016-02-08

Published by: Venture Planning Group (VPG)

Prices Starting From:
$6400

Stomach Cancer Forecast in 17 Major Markets 2016-2026 [Report Updated: 01-02-2016]

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Stomach Cancer in 17 Major MarketsStomach cancer is a broad term encompassing tumours arising in the stomach and includes gastric carcinoma which is a malignant epithelial-origin tumour commonly developing after prolonged periods of gastritis. Stomach cancers tend to develop slowly over many years spreading in different ways. Lo...Read More >>>

Published:
2016-02-01

Published by: Black Swan Analysis

Prices Starting From:
$6100

Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast (2016-2021) [Report Updated: 22-01-2016]

An alpha-fetoprotein (AFP) test is a blood test that measures the amount of AFP present in blood. It’s usually part of what’s called a triple screen or quad screen in the second trimester of pregnancy. The AFP protein found in humans is encoded by the AFP gene that is located on chromosome 4. The yolk sac and immature liver of an unborn baby produce AFP which then circulates through the fetal ...Read More >>>

Published:
2016-01-22

Published by: Industry ARC

Prices Starting From:
$5250

Smart Pills Market: By Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring); By Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & By Region-Forecast (2016-2022) [Report Updated: 05-01-2016]

Smart pill technology is the latest revolutionary technological advancement in healthcare practice which has helped in reducing the gap between healthcare and digital technology. Smart pills or Nootropics are basically medical devices and small embedded electronic appliances such as sensors, cameras and trackers which can be easily swallowed by a patient to get a complete evaluation of the gastroi...Read More >>>

Published:
2016-01-05

Published by: Industry ARC

Prices Starting From:
$5250

Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer), Product, and End Users & Region - Global Forecast to 2020 [Published by MarketsandMarkets]

The global tissue diagnostics market is valued at USD 3,202.5 million in 2015 and expected to reach USD 4,471.1 million by 2020, at a CAGR of 6.9% from 2015 to 2020. The global tissue diagnostics market is segmented based on products, technology, diseases, and end users. On the basis of product, the tissue diagnostics market is segmented into instruments and consumables. The instruments product se...Read More >>>

Published:
2015-12-02

Published by: MarketsandMarkets

Prices Starting From:
$5650

Companion Diagnostics Market: By Technology (PCR, Polymerase Chain Reaction (PCR), ISH, IHC, Others) Applications (Breast Cancer, Lung Cancer, Gastric Cancer, Others) End Users (Pharmaceuticals, Laboratries, Research Institutes, Others)-Forecast(2017-2022) [Report Updated: 18-07-2015]

Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients. The companion diagnostic is crucial for the safe and effective use of the drug and have been widely developed for myriad of cancer and other therapies. Each companion diagnostic test is specifically designed to be paired with a specific drug. Such tests can also save s...Read More >>>

Published:
2015-07-18

Published by: Industry ARC

Prices Starting From:
$5250

Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020 [Published by MarketsandMarkets]

According to the CDC, cancer is the second leading cause of mortality, causing ~584,881 deaths worldwide in 2013. Early diagnosis is the key to prevent the rising number of cancer-related deaths. The global cancer diagnostics market is witnessing a rapid transformation owing to several technological advancements in diagnostic platforms such as next-generation sequencing, DNA microarrays, and polym...Read More >>>

Published:
2015-06-10

Published by: MarketsandMarkets

Prices Starting From:
$5650

Smart Pills Market by Application (Capsule Endoscopy, Drug Delivery, Patient Monitoring), Target Area (Esophagus, Stomach, Small Intestine, Large Intestine) & Geography - Global Forecast to 2024 [Published by MarketsandMarkets]

The healthcare industry is witnessing a paradigm shift from traditional devices to more sophisticated and programmed ones. Growing demand for noninvasive procedures, sophisticated drug delivery techniques, and improved patient monitoring solutions are propelling the growth of this market. Companies are increasingly focusing on investing in R&D activities for the development of the smart pills tech...Read More >>>

Published:
2015-03-25

Published by: MarketsandMarkets

Prices Starting From:
$5650